Difficulty: Intermediate | Prerequisites: Basic understanding of psychological disorders and the DSM-5 classification system.
This material covers three conceptual topics that the AP Psychology exam frequently tests alongside case-study diagnosis: the pros and cons of diagnostic labelling, the biopsychosocial model as applied to depression, and the multifactorial development of schizophrenia. These are the "why" and "how" behind the disorders, whereas the companion study notes on diagnosing disorders cover the "what." If you are not yet comfortable identifying panic disorder, OCD, and other disorders from a symptom list, review those notes first.
Diagnostic labels give clinicians a shared vocabulary and guide treatment, but they carry real risks: stigma, cultural bias, and reducing complex human experience to a single category. The biopsychosocial model explains depression (and other disorders) as the product of biology, psychology, and social environment working together, not any single cause. Schizophrenia follows the same multifactorial logic: genetics load the gun, brain chemistry and structure shape vulnerability, and environmental and social stressors pull the trigger.
Diagnostic label
A formal name assigned to a pattern of symptoms based on a classification system such as the DSM-5, used to communicate about mental health conditions across clinical, research, and insurance contexts.
Think of it as: a shorthand that lets everyone involved in a patient's care talk about the same condition without describing every symptom from scratch each time.
Biopsychosocial model
A framework for understanding health and illness that considers the interaction of biological factors (genetics, neurochemistry), psychological factors (thoughts, emotions, personality), and social factors (relationships, culture, socioeconomic status).
In simple terms, this means no single cause explains a disorder. Biology, mind, and environment all contribute, and effective treatment often needs to address more than one of them.
Neurotransmitter
A chemical messenger that transmits signals across synapses between neurons. Imbalances in specific neurotransmitters are associated with various mental disorders.
Think of it as: the chemical language neurons use to talk to each other. When the balance is off, mood, thought, and behaviour can be affected.
Serotonin
A neurotransmitter involved in regulating mood, sleep, appetite, and anxiety. Low serotonin activity is associated with depression and anxiety disorders.
In simple terms, this means the "mood-stabilising" chemical. Most common antidepressants (SSRIs) work by increasing serotonin availability.
Dopamine
A neurotransmitter involved in reward, motivation, and motor control. Excess dopamine activity in certain brain pathways is associated with the positive symptoms of schizophrenia.
Think of it as: the "reward and drive" chemical. Too much activity in the wrong pathways can produce hallucinations and delusions.
Glutamate
The brain's primary excitatory neurotransmitter. Dysregulation of glutamate has been implicated in schizophrenia, alongside dopamine.
In simple terms, this means the chemical that makes neurons fire. When glutamate signalling goes wrong, it may contribute to the cognitive and perceptual disturbances seen in schizophrenia.
Genetic predisposition
An inherited increase in the likelihood of developing a particular condition, based on the genes passed down from biological parents.
Think of it as: a loaded deck, not a guaranteed outcome. Having the genes raises your risk, but environmental and psychological factors determine whether the disorder develops.
Rumination
A pattern of repetitively and passively dwelling on negative thoughts, feelings, and their causes and consequences, without moving toward problem-solving.
In simple terms, this means getting stuck in a mental loop of "why do I feel this way" and "what's wrong with me" without doing anything about it. It worsens depression.
Neuroticism
A personality trait characterised by a tendency toward negative emotional states such as anxiety, sadness, and irritability. Higher neuroticism is a risk factor for depression and anxiety disorders.
Think of it as: an emotional thermostat set too sensitive, so minor stressors produce outsized distress.
Enlarged ventricles
A structural brain abnormality observed in some individuals with schizophrenia, where the fluid-filled spaces in the brain are larger than typical, often associated with reduced surrounding brain tissue.
In simple terms, this means the brain's internal cavities are bigger than normal, which suggests less brain tissue overall. It is a correlational finding, not a cause, and not present in every person with schizophrenia.
Tags: diagnostic labels, DSM-5, stigma, cultural bias, misdiagnosis, clinical communication, treatment planning
Benefits of diagnostic labels
Common clinical language: a label like "major depressive disorder" lets psychiatrists, psychologists, GPs, and researchers communicate precisely without lengthy symptom descriptions
Treatment selection: different diagnoses call for different interventions. A panic disorder diagnosis points toward CBT and SSRIs; a bipolar diagnosis points toward mood stabilisers. Without the label, treatment is guesswork
Patient understanding: a diagnosis can help patients make sense of their experience, access support groups, and find relevant information
Research facilitation: standardised labels allow researchers to study the same condition across different populations and compare treatment outcomes
Drawbacks of diagnostic labels
Stigma and discrimination: a psychiatric label can follow a person into employment, insurance, and social relationships. People may be reduced to their diagnosis ("she's schizophrenic" rather than "she has schizophrenia")
Oversimplification: a label captures a pattern of symptoms but can miss the unique texture of an individual's experience. Two people with the same diagnosis may have very different symptom profiles and life circumstances
Cultural bias: diagnostic criteria were developed primarily in Western clinical settings. Behaviours that are normal or valued in one culture may be pathologised in another, leading to misdiagnosis or underdiagnosis in certain populations
Insurance and access distortions: the need for a billable diagnosis can push clinicians toward labelling patients who fall in grey areas, and lack of insurance coverage can prevent people from receiving a thorough evaluation
Tags: biopsychosocial model, depression, biological factors, psychological factors, social factors, serotonin, dopamine, neurotransmitter imbalance, cognitive patterns, rumination, neuroticism, stress, trauma, social isolation
The biopsychosocial model holds that depression arises from the interaction of three categories of influence, not from any one alone. The AP exam tests your ability to identify which factor belongs to which category and to explain how they interact.
Biological factors
Genetic predisposition: depression runs in families. Having a first-degree relative with depression roughly doubles or triples the risk
Neurotransmitter imbalances: low serotonin and dopamine activity are associated with depressive symptoms. This is the basis for SSRI and SNRI medications
Brain structure and function: changes in the prefrontal cortex and hippocampus have been observed in people with chronic depression, including reduced hippocampal volume
Psychological factors
Cognitive patterns: Aaron Beck's cognitive triad describes how depressed individuals hold negative views of themselves, the world, and the future. Rumination (repetitively dwelling on distress without problem-solving) deepens depression
Learned helplessness: Martin Seligman's research showed that when organisms learn they cannot control negative outcomes, they stop trying, even when escape becomes possible. This maps onto the passivity and hopelessness seen in depression
Personality traits: high neuroticism (tendency toward negative emotions) and perfectionism are risk factors
Social factors
Stressful life events: job loss, bereavement, relationship breakdown, and chronic financial stress are common triggers
Trauma: childhood abuse, neglect, and adverse childhood experiences (ACEs) significantly increase lifetime risk of depression
Social isolation: lack of a supportive social network removes a key protective factor. Loneliness and depression reinforce each other in a feedback loop
How the factors interact
A person with a genetic vulnerability (biological) who develops a ruminative thinking style (psychological) and then loses a close relationship (social) is at much higher risk than someone facing any one of those factors alone. Effective treatment often addresses multiple layers: medication for the neurotransmitter imbalance, CBT for the cognitive patterns, and social interventions to reduce isolation.
Tags: schizophrenia development, dopamine hypothesis, glutamate hypothesis, genetics of schizophrenia, enlarged ventricles, prenatal factors, diathesis-stress model, urban environment risk
Schizophrenia is the textbook example of a disorder that no single cause explains. The AP exam expects you to name factors from each category and explain how they interact.
Genetics
Schizophrenia runs in families. The concordance rate for identical twins is roughly 48%, meaning genetics matter but are not the whole story
Multiple genes appear to contribute, each with a small effect. There is no single "schizophrenia gene"
The diathesis-stress model captures this well: genetic vulnerability (diathesis) interacts with environmental stress to produce the disorder
Brain chemistry
The dopamine hypothesis: excess dopamine activity in the mesolimbic pathway is associated with positive symptoms (delusions, hallucinations). Antipsychotic medications work primarily by blocking dopamine receptors
The glutamate hypothesis: reduced glutamate signalling may contribute to both positive and negative symptoms. This is a more recent line of research and is less well established than the dopamine hypothesis
Brain structure
Enlarged ventricles (the fluid-filled spaces in the brain) have been observed in some patients, suggesting reduced surrounding brain tissue
Decreased grey matter volume, particularly in the prefrontal cortex and temporal lobes, has been documented
These are correlational findings. They appear more often in people with schizophrenia but are not diagnostic on their own
Environmental factors
Prenatal exposure to viruses (e.g. influenza during the second trimester), malnutrition, or toxins during foetal development is associated with increased risk
Birth complications involving oxygen deprivation may contribute
Childhood trauma, abuse, or severe stress can raise the risk in genetically vulnerable individuals
Social factors
Poverty, social isolation, and urban living are associated with higher rates of schizophrenia
Migration and minority-group stress have also been linked to increased risk, possibly through chronic social adversity
These social stressors likely interact with genetic and biological factors rather than causing the disorder independently
The biopsychosocial model is the standard framework used in clinical intake assessments. When a psychiatrist or psychologist evaluates a new patient, they systematically ask about family history (biological), thought patterns and coping style (psychological), and life stressors and social support (social). This is how clinicians avoid tunnel vision: a patient who presents with depression after a job loss still needs their family history of mood disorders checked, because the treatment plan may differ if there is a strong genetic component.
Diagnostic labels have direct practical consequences. In the United States, insurance reimbursement typically requires a DSM-5 diagnosis code. A clinician who cannot assign a label may struggle to get their patient's treatment covered, which is one reason the labelling debate matters beyond theory.
Schizophrenia research has led to the development of antipsychotic medications that target dopamine pathways, the single most direct translation from brain-chemistry research to treatment. Newer research on glutamate is driving work on next-generation medications that may address symptoms current drugs do not reach.
Students often treat the biopsychosocial model as though the three categories are separate and independent. They are not. The whole point is their interaction: a genetic vulnerability changes how someone responds to stress, and social isolation changes brain chemistry. The exam rewards answers that show interaction, not just listing one factor from each column.
Students sometimes assume that diagnostic labels are either entirely good or entirely bad. The exam wants a balanced answer: labels are useful clinical tools with real drawbacks. A one-sided response will lose marks.
Students frequently believe that "chemical imbalance" is a proven, complete explanation for depression. The neurotransmitter model is one contributor among many. Depression involves cognitive, social, and structural brain factors alongside neurotransmitter activity.
Students often think schizophrenia is purely genetic because it runs in families. The 48% concordance rate in identical twins means that even with identical DNA, more than half of co-twins do not develop the disorder. Environment and experience matter.
The biopsychosocial model is one of the most commonly tested frameworks on the AP Psychology exam. Be prepared to apply it to any disorder, not just depression.
Free-response questions on abnormal psychology frequently ask you to "explain from a biological, psychological, and social perspective." The biopsychosocial model is your template for answering these.
The benefits and drawbacks of diagnostic labels are a classic short-answer topic. Memorise at least two benefits and two drawbacks with concrete examples.
The dopamine hypothesis of schizophrenia is frequently tested. Know what it claims, what evidence supports it (antipsychotics block dopamine and reduce positive symptoms), and its limitations (it does not explain negative symptoms well).
Twin studies and concordance rates are a standard way the exam tests the genetics-versus-environment question. The 48% concordance rate for schizophrenia in identical twins is a figure worth remembering.
True or False: The biopsychosocial model argues that mental disorders have a single root cause that falls into one of three categories.
Answer: False. The model argues that biological, psychological, and social factors interact to produce disorders. No single factor is sufficient.
Fill in the blank: The _______ hypothesis proposes that excess dopamine activity in the mesolimbic pathway contributes to the positive symptoms of schizophrenia.
Answer: dopamine.
True or False: One benefit of diagnostic labels is that they allow researchers to study the same condition across different populations.
Answer: True.
Fill in the blank: The concordance rate for schizophrenia in identical twins is approximately _______%, which demonstrates that genetics alone do not determine the disorder.
Answer: 48.
True or False: Diagnostic labels are free from cultural bias because the DSM-5 is based on scientific research.
Answer: False. The DSM-5 criteria were developed primarily in Western clinical settings and may pathologise behaviours that are normal in other cultures.
Q: Name two benefits and two drawbacks of using diagnostic labels in mental health.
A: Benefits: (1) they provide a common language for clinicians to communicate and coordinate treatment; (2) they guide treatment selection, as different diagnoses call for different interventions. Drawbacks: (1) they can lead to stigma and discrimination; (2) they may oversimplify complex individual experiences and miss important nuances.
Q: Using the biopsychosocial model, explain how depression might develop in a person who has a family history of mood disorders, a tendency toward rumination, and recently lost their job.
A: The family history represents a biological vulnerability (genetic predisposition to neurotransmitter imbalances). The ruminative thinking style is a psychological factor that amplifies negative emotions and prevents effective coping. The job loss is a social stressor that removes structure, income, and social contact. These three factors interact: the genetic vulnerability makes the person's brain chemistry more sensitive to stress, the rumination prevents them from adapting psychologically, and the job loss provides the triggering event.
Q: What does the dopamine hypothesis of schizophrenia propose, and what is the main evidence supporting it?
A: The dopamine hypothesis proposes that excess dopamine activity in certain brain pathways (particularly the mesolimbic pathway) contributes to the positive symptoms of schizophrenia, such as delusions and hallucinations. The main evidence is that antipsychotic medications, which block dopamine receptors, are effective at reducing these positive symptoms.
Q: Why does the 48% concordance rate for schizophrenia in identical twins support the biopsychosocial model rather than a purely genetic explanation?
A: If schizophrenia were purely genetic, identical twins (who share 100% of their DNA) would have a concordance rate near 100%. The 48% rate shows that genetics create vulnerability but environmental and psychological factors determine whether the disorder develops, which is exactly what the biopsychosocial model predicts.
Q: How might cultural bias affect the accuracy of diagnostic labels?
A: Diagnostic criteria developed in Western clinical settings may not account for how symptoms are expressed or understood in other cultures. Behaviours considered normal or even valued in one culture (e.g. hearing the voice of a deceased ancestor) might be classified as pathological under Western criteria, leading to misdiagnosis. Conversely, genuine distress expressed in culturally specific ways may go unrecognised if it does not match the expected symptom profile.
Q: Explain how environmental factors during prenatal development might contribute to schizophrenia later in life.
A: Exposure to viruses (such as influenza during the second trimester), malnutrition, or toxins during foetal development has been associated with increased risk of schizophrenia. These prenatal insults may disrupt normal brain development, creating structural or chemical vulnerabilities that remain dormant until triggered by stress or hormonal changes in adolescence or early adulthood.
The biopsychosocial model connects to virtually every disorder covered in the AP Psychology abnormal psychology unit. Once you understand the framework for depression, you can apply the same three-column analysis to anxiety disorders, eating disorders, substance use disorders, and personality disorders. The exam rewards this transferable thinking.
Diagnostic labelling connects to the research methods unit: understanding how researchers define and operationalise a disorder (using DSM criteria) is essential for evaluating the validity of studies on treatment effectiveness.
The genetics and neurotransmitter content here ties directly to the biological bases of behaviour unit. Dopamine, serotonin, and glutamate appear across multiple topics: reward and motivation (dopamine), mood regulation (serotonin), and neural excitation (glutamate). Studying them here reinforces material you will need elsewhere.
Diagnostic labels, DSM-5, benefits of diagnosis, drawbacks of diagnosis, stigma in mental health, cultural bias in diagnosis, biopsychosocial model, biological factors in depression, psychological factors in depression, social factors in depression, neurotransmitter imbalance, serotonin, dopamine, glutamate, genetic predisposition, rumination, neuroticism, learned helplessness, Aaron Beck cognitive triad, Martin Seligman, diathesis-stress model, dopamine hypothesis, schizophrenia development, enlarged ventricles, grey matter, prenatal risk factors, twin concordance rate, social isolation, urban environment risk, AP Psychology abnormal psychology, free-response abnormal psych